Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled study.
(2012) Digestive and Liver Disease — Vol. 44, n° 7, p. 603-609 (2012)
Files
Belli-2012-Antiviraltherapyandfibrosis.pdf
Restricted Access - Adobe PDF
- 331.46 KB
Details
- Authors
- Abstract
- We evaluated the effect of antiviral therapy on fibrosis progression in patients with histological features of mild/moderate HCV disease recurrence defined by a Grading score≥4 and Staging score up to 3 (Ishak) at 1 year after liver transplantation.
- Affiliations
Citations
Belli, L. S., Volpes, R., Graziadei, I., Fagiuoli, S., Starkel, P., Burra, P., Alberti, A. B., Gridelli, B., Vogel, W., Pasulo, L., De Martin, E., Guido, M., De Carlis, L., Lerut, J., Cillo, U., Burroughs, A. K., & Pinzello, G. (2012). Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled study. Digestive and Liver Disease, 44(7), 603-609. https://doi.org/10.1016/j.dld.2012.01.017 (Original work published 2012)